A little innovation. Baylor launches biotech firm to sell cancer therapy.
Barr
Paul
P
D001709:Biotechnology / Q000191:economics*; D019496:Cancer Vaccines / Q000191:economics; D064987:Cell- and Tissue-Based Therapy / Q000191:economics; D003713:Dendritic Cells / Q000637:transplantation; D016520:Entrepreneurship; D006754:Hospital Restructuring / Q000331:legislation & jurisprudence*; D006801:Humans; D012109:Research Support as Topic; D013781:Texas
D019496:Cancer Vaccines